Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage

specific

A finding of acute myeloid leukemia due to lineage switch from acute leukemia of ambiguous lineage, that is resistant to treatment.

29

Centers

29

Active Trials

—

Cancer Funding

Top Centers for Refractory Acute Myeloid Leukemia Due to Lineage Switch From Acute Leukemia of Ambiguous Lineage(29)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
Active Research Program
51.7
2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
Active Research Program
51.7
3
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
Active Research Program
51.7
4
Vanderbilt-Ingram Cancer CenterNashville, TN
NCI Comprehensive
Active Research Program
51.7
5
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
Active Research Program
51.7
6
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
51.7
7
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
51.7
8
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
51.7
9
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
51.7
10
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
51.7
11
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.7
12
University of Colorado Cancer CenterAurora, CO
NCI Comprehensive
Active Research Program
51.7
13
UF Health Cancer InstituteGainesville, FL
NCI Clinical
Active Research Program
51.7
14
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
Active Research Program
51.7
15
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
Active Research Program
51.7
16
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
Active Research Program
51.7
17
Holden Comprehensive Cancer CenterIowa City, IA
NCI Comprehensive
Active Research Program
51.7
18
Fred & Pamela Buffett Cancer CenterOmaha, NE
NCI Clinical
Active Research Program
51.7
19
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
51.7
20
University of Illinois Cancer CenterChicago, IL
Active Research Program
51.7
21
University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM
NCI Comprehensive
Active Research Program
51.7
22
UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR
Active Research Program
51.7
23
Houston Methodist Dr. Mary and Ron Neal Cancer CenterHouston, TX
Active Research Program
51.7
24
Cancer Center at IllinoisUrbana, IL
Active Research Program
51.7
25
University of Cincinnati Cancer CenterCincinnati, OH
Active Research Program
51.7
26
Livestrong Cancer InstitutesAustin, TX
Active Research Program
51.7
27
Upstate Cancer CenterSyracuse, NY
Active Research Program
51.7
28
Loma Linda University Cancer CenterLoma Linda, CA
Active Research Program
51.7
29
BC CancerVancouver, BC
Active Research Program
51.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →